LM-1685

a celecoxib analogue, reduced the proliferation and survival of seven human cancer cell lines by at least one log over either agent alone

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 05/01/2005 - "We found that continuous exposure to cytostatic doses of CAI and LM-1685, a celecoxib analogue, reduced the proliferation and survival of seven human cancer cell lines by at least one log (P < or = 0.001) over either agent alone. "